Development of a practical, asymmetric synthesis of the hepatitis C virus protease inhibitor MK-5172.
The development of a practical, asymmetric synthesis of the hepatitis C virus (HCV) protease inhibitor MK-5172 (1), an 18-membered macrocycle, is described.